Person:
UMURHAN AKKAN, JÜLİDE CANAN

Profile Picture
Google ScholarScopusORCIDPublons
Status
Organizational Units
OrgUnit Logo
Organizational Unit
Job Title
First Name
JÜLİDE CANAN
Last Name
UMURHAN AKKAN
Name
Email Address
Birth Date

Filters

20142
Reset filters

Settings

Start date: 2011 × End date: 2020 × Rights: info:eu-repo/semantics/openAccess × Author: AYINTAP, Emre ×

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    PublicationMetadata only
    Repeated bevacizumab injections versus mitomycin C in rotational conjunctival flap for prevention of pterygium recurrence
    (2014-04-01) ÖZSÜTÇÜ, Mustafa; AYINTAP, Emre; Akkan, JÜLİDE CANAN; KOYTAK, Arif; ARAS, Cengiz; UMURHAN AKKAN, JÜLİDE CANAN; KOYTAK, İBRAHİM ARİF
    Aims: To evaluate the efficacy of repeated bevacizumab injection in rotational conjunctival flap surgery versus rotational conjunctival flap with adjunctive mitomycin C (MMC) or rotational conjunctival flap alone. Materials and methods: Ninety eyes of 90 patients who underwent primary pterygium surgery with rotational flap were evaluated. Patients were randomly assigned to undergo conjunctival rotational flap alone (Group A) or conjunctival rotational flap with either 0.02% MMC application (Group B) or adjunctive subconjunctival 2.5 mg/0.1 ml bevacizumab injection (Group C). Each group consisted of 30 eyes. Recurrence rates at 9 months were evaluated. Results: There were no statistically significant differences in mean size of the pterygium across the limbus in terms of length (P > 0.5). The recurrence rates at 9 months were 26.6% (n = 8) in Group A, 13.3% (n = 4) in Group B, and 10% (n = 3) in Group C. The recurrence rates in Group B and C were significantly lower than in Group A (P = 0.1806). The recurrence rates were similar in Group B and C (P > 0.05). Conclusions: Subconjunctival bevacizumab injection may decrease the recurrence rate of primary pterygium surgery with rotational conjunctival flap. Further studies with a larger population and longer follow-up period are needed to supplement this study.
  • Thumbnail Image
    PublicationOpen Access
    Analysis of Age as a Possible Prognostic Factor for Transcanalicular Multidiode Laser Dacryocystorhinostomy
    (2014-01-01) AYINTAP, Emre; BUTTANRI, Ibrahim Bulent; SADIGOV, Fariz; SERIN, Didem; ÖZSÜTÇÜ, Mustafa; Akkan, JÜLİDE CANAN; TUNCER, Kemal; UMURHAN AKKAN, JÜLİDE CANAN
    Purpose. To assess the prognostic value of age on the outcome of transcanalicular multidiode laser dacryocystorhinostomy (TCL-DCR) in patients with acquired nasolacrimal duct obstruction (NLDO). Methods. The medical records of TCL-DCR performed between March 2009 and September 2013 were reviewed retrospectively. Inclusion criteria include over 20 years of age, similar mean follow-up period, and similar mean duration of stenting. The main outcome is surgical success. The effect of age on success rate is also evaluated. Results. The anatomical success was 52% in Group 1 (20-30 years), 56% in Group 2 (31-40 years), 64% in Group 3 (41-50 years), 76% in Group 4 (51-60 years), and 88% in Group 5 (over 60 years). The statistical difference among Group 1 and Group 5, in terms of surgical success rate, was found to be significant (P = 0.009). Additionally, the 20-30-year-old patients had a failure rate 6.76 times higher than that of the over-60-year-old patients (P = 0.009; 95% CI, 1.605-28.542). Conclusion. TCL-DCR is a surgical treatment option for NLDO for which a skin incision can be avoided. The success rate of TCL-DCR for younger population is lower when compared with elderly population.